OR WAIT null SECS
More attention should be given to how expert opinions and judgments are elicited for reducing uncertainty in quality risk management and risk-based decision making.
There are key elements that should be covered when dealing with third-party auditors, according to Siegfried Schmitt, vice president, Technical, at Parexel.
The EU’s AI Act is set to become the world’s first comprehensive legal framework for artificial intelligence.
November 03, 2023
Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.
This is the second biologic approved to treat HS, a painful and reoccurring skin disease.
The EC is calling for interested parties for their safety and orphan drug committees.
According to USP, the products will advance quality and reduce risk in the development and manufacture of biologics and vaccines.
One of the main purposes of stability testing is to establish shelf life for these drug products. The goal of this paper is to create an Excel spreadsheet, which can be used for statistical testing of more than three stability batches for poolability.
November 02, 2023
A novel approach for safety assessments in inhalation drugs may avoid animal testing for drug products.
Pharmaceutical Technology Europe® spoke with Joren van der Horst from Luo Automation, a Dutch company focused on automated visual inspection solutions, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.